As India's corporate workforce continues to support global operations around the clock, healthcare experts are raising concerns about the long term impact of night shifts on employee health. While shift based work has become common across IT, healthcare, BPO, aviation, manufacturing, and customer support sectors,
The Kalam Institute of Health Technology (KIHT), a WHO Collaborating Centre for Health Innovation based at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, is a healthcare technology institute focused on health technology assessment, clinical research, regulatory science, and healthcare innovation, has received official approval from the Government of India to
As the pharmaceutical, nutraceutical, and herbal wellness industries continue to witness rapid growth, the need for dependable and quality driven supply partners has become more crucial than ever. In this evolving business landscape, Star Bio Pharma has emerged as a growing force in the domain of B2B pharmaceutical
Senores Pharmaceuticals Limited reported strong financial and operational performance for the fourth quarter and full year ended March 31, 2026, reflecting sustained growth across regulated markets, emerging markets, and branded generics businesses. The research driven pharmaceutical company announced its audited financial results highlighting significant expansion in revenues, profitability, and
“Poised for Takeoff: MedTech in India” report launched at the national policy platform attended by over 450 delegates and 70+ eminent speakers from government, industry, research institutions, and healthcare ecosystems The 3rd Edition of MedTech Policy Mahotsav 2026, organized by Global MedTech Advocacy & Advisory Forum
India and Japan have strengthened their bilateral science and technology partnership through new agreements focused on quantum technology, healthcare innovation, medical research, and advanced computing, marking a significant step in expanding cooperation in critical and emerging technologies. The agreements were formalised during a high level
Global life sciences leader Thermo Fisher Scientific has introduced a new integrated platform designed to accelerate and scale cell therapy manufacturing, marking a significant advancement in the rapidly evolving field of advanced therapeutics. The platform brings together end to end solutions across the cell therapy workflow
The company aims to expand its presence significantly with this new product line Witnesses massive response in the initial launch phase KeyCi empowers individuals through skincare, rooted in science and sustainability Iberia Pharmaceuticals, a leading name in pharmaceutical industry, has announced an overwhelming response to the initial launch
India and Japan reinforced their bilateral healthcare collaboration at the 3rd Joint Committee Meeting (JCM) on Healthcare held at Bharat Mandapam. The meeting, held under the India Japan Memorandum of Cooperation in Healthcare and Wellness, was co chaired by Union Health Minister Jagat Prakash Nadda
Global life sciences leader Thermo Fisher Scientific has announced an agreement to sell its microbiology business to European private equity firm Astorg for approximately $1.075 billion. The move is part of Thermo Fisher’s ongoing strategy to streamline its portfolio and focus on high growth, high
